What is Avalo Therapeutics's total cost of revenue?

Avalo Therapeutics (AVTX) reported total cost of revenue of $0 in Q2 2025.

How has Avalo Therapeutics's total cost of revenue changed year-over-year?

Avalo Therapeutics's total cost of revenue decreased by 100.0% year-over-year, from $343K to $0.

What does total cost of revenue mean?

The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Avalo Therapeutics AVTX Total Cost of Revenue

Discontinued — last reported Q2 '25

Total Cost of Revenue at other companies

Eli LillyLLY

$3.58B+60.8%

AbbVieABBV

$4.22B+5.4%

ImmunityBio, Inc.IBRX

$238K+310%

Aurinia PharmaceuticalsAUPH

$6.51M-24.1%

Kiniksa Pharmaceuticals International, plcKNSA

$20.8M+16.4%

TG TherapeuticsTGTX

$33.51M+116%

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,783%

Enterprise value$929.6M-1,342%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Avalo Therapeutics’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's total cost of revenue?: Avalo Therapeutics (AVTX) reported total cost of revenue of $0 in Q2 2025.
How has Avalo Therapeutics's total cost of revenue changed year-over-year?: Avalo Therapeutics's total cost of revenue decreased by 100.0% year-over-year, from $343K to $0.
What does total cost of revenue mean?: The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.